| Idiopathic pulmonary fibrosis: pathogenesis and management |
52 |
| Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes |
40 |
| The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis |
38 |
| Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology |
38 |
| Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes |
31 |
| Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat |
31 |
| Interstitial lung disease associated with systemic sclerosis (SSc-ILD) |
30 |
| Macrophages: friend or foe in idiopathic pulmonary fibrosis? |
29 |
| Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? |
26 |
| Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis |
25 |
| Regulation of alveolar macrophage death in acute lung inflammation |
25 |
| Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry |
24 |
| Exhaled particles and small airways |
24 |
| A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement |
24 |
| The pathology of small airways disease in COPD: historical aspects and future directions |
23 |
| The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry |
22 |
| Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease |
21 |
| Isolation and characterization of extracellular vesicles from Broncho-alveolar lavage fluid: a review and comparison of different methods |
20 |
| Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema |
20 |
| Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
20 |
| LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT(1)R via sponging let-7b in monocrotaline-induced pulmonary arterial hypertension |
19 |
| Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis |
19 |
| The natural history of progressive fibrosing interstitial lung diseases |
18 |
| Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis |
18 |
| Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial |
18 |
| Pollution and respiratory disease: can diet or supplements help? A review |
17 |
| Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study |
16 |
| Urban particulate matter (PM) suppresses airway antibacterial defence |
16 |
| Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: the role of Nrf2 antioxidant system in preventing oxidative stress |
15 |
| Circulating microRNAs and prediction of asthma exacerbation in childhood asthma |
14 |
| Trends in mortality from pneumonia in the Europe union: a temporal analysis of the European detailed mortality database between 2001 and 2014 |
14 |
| miR-335-5p inhibits TGF-beta 1-induced epithelial-mesenchymal transition in non-small cell lung cancer via ROCK1 |
14 |
| Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients |
14 |
| From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy |
14 |
| Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study |
14 |
| Differential effects of innate immune variants of surfactant protein-A1 (SFTPA1) and SP-A2 (SFTPA2) in airway function after Klebsiella pneumoniae infection and sex differences |
13 |
| Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC in epithelium of asthmatics |
13 |
| Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens |
13 |
| BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials |
13 |
| Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial |
13 |
| Circular RNAs: a rising star in respiratory diseases |
13 |
| The prostaglandin D-2 receptor 2 pathway in asthma: a key player in airway inflammation |
13 |
| Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis |
13 |
| Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD |
13 |
| Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia |
13 |
| Risk factors for diagnostic delay in idiopathic pulmonary fibrosis |
12 |
| Airway disease phenotypes in animal models of cystic fibrosis |
12 |
| Noninvasive high-frequency oscillatory ventilation as respiratory support in preterm infants: a meta-analysis of randomized controlled trials |
12 |
| GM-CSF overexpression after influenza a virus infection prevents mortality and moderates M1-like airway monocyte/macrophage polarization |
12 |
| Use of precision cut lung slices as a translational model for the study of lung biology |
12 |
